- Conditions
- Autism Spectrum Disorder
- Interventions
- SENSE Theatre, Tackling Teenage Together
- Behavioral
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 8 Years to 16 Years
- Enrollment
- 318 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2023
- U.S. locations
- 3
- States / cities
- Tuscaloosa, Alabama • Stony Brook, New York • Nashville, Tennessee
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 529–552
of 1,590
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Autism, Autism Spectrum Disorder
- Interventions
- GuessWhat Mobile App
- Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 541 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- ASD, Autism Spectrum Disorder
- Interventions
- 98% pure CBD
- Drug
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 7 Years to 17 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Achondroplasia
- Interventions
- Infigratinib is provided as a single dose of minitablets for oral administration, Infigratinib is provided as sprinkle capsules for daily oral administration, Infigratinib or placebo comparator is provided as sprinkle capsules for daily oral administration
- Drug
- Lead sponsor
- QED Therapeutics, a BridgeBio company
- Industry
- Eligibility
- 0 Years to 32 Months
- Enrollment
- 77 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2032
- U.S. locations
- 3
- States / cities
- Oakland, California • Baltimore, Maryland • Madison, Wisconsin
- Conditions
- Autism
- Interventions
- CM-AT
- Drug
- Lead sponsor
- Curemark
- Industry
- Eligibility
- 9 Years to 12 Years
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 19
- States / cities
- Phoenix, Arizona • Sacramento, California • San Francisco, California + 16 more
- Conditions
- Autism Spectrum Disorders, Autism
- Interventions
- Not listed
- Lead sponsor
- The Vista School
- Other
- Eligibility
- 8 Months to 6 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Hershey, Pennsylvania
- Conditions
- Dwarfism, Growth Disorder
- Interventions
- Deslorelin
- Drug
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- Not listed
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1983 – 2001
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- HIV Infections
- Interventions
- Not listed
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Eligibility
- 6 Years and older
- Enrollment
- 54 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2014
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Healthy Children, Children With Neurodevelopmental Disorders, Children With Neuropsychiatric Disorders, Children With Behavioral Syndromes
- Interventions
- Not listed
- Lead sponsor
- National Institute of Mental Health (NIMH)
- NIH
- Eligibility
- 6 Months to 8 Years
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Autism Spectrum Disorder
- Interventions
- Behavioral skills training, Protocol Only
- Behavioral
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- Not listed
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Autistic Disorder
- Interventions
- Pivotal Response Training, Picture Exchange Communication System
- Behavioral
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 24 Months to 47 Months
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 2
- States / cities
- La Jolla, California • Santa Barbara, California
- Conditions
- Autism Spectrum Disorder
- Interventions
- ABA therapy enhanced with V-Motive software
- Behavioral
- Lead sponsor
- Experiad LLC
- Industry
- Eligibility
- 4 Years and older
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Bellevue, Washington
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Closed Loop (Medtronic 670G), Standard Care
- Device · Other
- Lead sponsor
- Nemours Children's Clinic
- Other
- Eligibility
- 14 Years to 17 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 5
- States / cities
- Palo Alto, California • New Haven, Connecticut • Jacksonville, Florida + 2 more
- Conditions
- Autism, Autism Spectrum Disorder
- Interventions
- MapHabit System (MHS)
- Behavioral
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 24 Years
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Phelan McDermid Syndrome
- Interventions
- Recombinant human Growth hormone
- Drug
- Lead sponsor
- Swathi Sethuram
- Other
- Eligibility
- 2 Years to 12 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Autism Spectrum Disorder
- Interventions
- Strengthening Skills Program, PEERS Social Skills Program
- Behavioral
- Lead sponsor
- Southwest Autism Research & Resource Center
- Other
- Eligibility
- 21 Years to 70 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Tempe, Arizona
- Conditions
- Pituitary Disease
- Interventions
- Pegvisomant
- Drug
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 2 Years to 18 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Autism Spectrum Disorder, Depression, Anxiety, Anxiety, Anger
- Interventions
- Group Behavioral Activation Therapy for Autism Spectrum Disorder
- Behavioral
- Lead sponsor
- Rutgers, The State University of New Jersey
- Other
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Piscataway, New Jersey
- Conditions
- Periodontitis, Autism, Premature Infants
- Interventions
- Not listed
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 1 Day and older
- Enrollment
- 331 participants
- Timeline
- 2007 – 2013
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • Chapel Hill, North Carolina • Durham, North Carolina + 1 more
- Conditions
- Autism
- Interventions
- Buspirone
- Drug
- Lead sponsor
- Chugani, Diane C.
- Individual
- Eligibility
- 2 Years to 6 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Autism, Pervasive Developmental Disorder
- Interventions
- oral zinc and vitamin C supplements, oral Placebo
- Drug · Other
- Lead sponsor
- Milton S. Hershey Medical Center
- Other
- Eligibility
- 3 Years to 8 Years
- Enrollment
- 89 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2011
- U.S. locations
- 1
- States / cities
- Hershey, Pennsylvania
- Conditions
- Autism Spectrum Disorder
- Interventions
- sapropterin dihydrochloride
- Drug
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 2 Years to 6 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Little Rock, Arkansas
- Conditions
- Weight Gain, Autism Spectrum Disorder, Medication Side Effect
- Interventions
- Comparison of Risperidone and Aripiprazole
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- Up to 17 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Autism, Autistic Disorder
- Interventions
- Gluten- and casein-free diet, Placebo controlled diet
- Behavioral
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 30 Months to 54 Months
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- Rochester, New York